Also tested to survive the acidic stomach environment
[DOI] [PubMed] [Google Scholar] 117.Wen J., Du Y., Li D., Alany R
Good candidates generally include seniors with: Type 2 diabetes and elevated BMI Cardiovascular disease risk factors where weight reduction would meaningfully reduce risk BMI of 30 or higher with weight-related comorbidities Adequate baseline nutritional status and no significant frailty Patients who warrant more caution include those with significant frailty, malnutrition risk, advanced chronic kidney disease, or a history of gastroparesis
( 10.4103/0970-1591.78437) [DOI] [PMC free article] [PubMed] [Google Scholar] Agarwal A, Virk G, Ong C, Du Plessis SS.2014
Moreover, visceral fat is likely to return in anyone who discontinues their tesamorelin therapy, whereas patients whove taken semaglutide (e.g., Ozempic) have seen at least some longer-lasting health outcomes after ending their treatment.14 29 Therefore, there are three takeaways about tesamorelin and abdominal fat: Tesamorelin may be able to reduce your morbidity for serious chronic health conditions
N Engl J Med 292(19):9859 Ghimire P, Dhamoon AS (2023) Ketoacidosis
